🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 00847X104
- Market Cap
- Large Cap · $3 Billion
- IPO
- 7/24/2013 · $18.00/share
Business: Agios Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering and developing novel investigational medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism and adjacent areas of biology. In addition to an active research and discovery pipeline across both therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.
Company Contact
- CEO
-
Jacqualyn Fouse
- CFO
- Andrew Hirsch
- Headquarters
- 38 Sidney Street, 2nd floor, Cambridge, MA 02139
- Phone
- 617-649-8600
- Investor Relations
- Holly Manning · 617-844-6630 · Holly.Manning@agios.com